ONCT - Oncternal Therapeutics GAAP EPS of -$0.21 beats by $0.03 revenue of $0.38M beats by $0.13M November, 03 2022 04:15 PM Oncternal Therapeutics Inc. Oncternal Therapeutics press release ( NASDAQ: ONCT ): Q3 GAAP EPS of -$0.21 (vs. -$0.19 Y/Y) beats by $0.03 . Revenue of $0.38M (-81.9% Y/Y) beats by $0.13M . For further details see: Oncternal Therapeutics GAAP EPS of -$0.21 beats by $0.03, revenue of $0.38M beats by $0.13M